Identification of two neutralizing human single-chain variable fragment antibodies targeting Staphylococcus aureus alpha-hemolysin
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 25، شماره: 10
سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 157
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-25-10_007
تاریخ نمایه سازی: 11 مهر 1401
چکیده مقاله:
Objective(s): The inability of the host immune system to defeat Staphylococcus aureus is due to various secreted virulent factors such as leukocidins, superantigens, and hemolysins, which interrupt the function of immune components. Alpha-hemolysin is one of the most studied cytolysins due to its pronounced effect on developing staphylococcal infections. Alpha-hemolysin-neutralizing antibodies are among the best candidates for blocking the toxin activity and preventing S. aureus pathogenesis. Materials and Methods: A human single-chain variable fragment (scFv) phage display library was biopanned against alpha-hemolysin. The selected phage clones were assessed based on their binding ability to alpha-hemolysin. The binding specificity and affinity of two scFvs (designated SP۱۹۲ and SP۲۲۰) to alpha-hemolysin were determined by enzyme-linked immunosorbent assay. Furthermore, the neutralizing activity of SP۱۹۲ and SP۲۲۰ was examined by concurrent incubation of rabbit red blood cells (RBCs) with alpha-hemolysin and scFvs.Results: SP۱۹۲ and SP۲۲۰ showed significant binding to alpha-hemolysin compared with the control proteins, including bovine serum albumin, human adiponectin, and toxic shock syndrome toxin-۱. Besides, both scFvs showed high-affinity binding to alpha-hemolysin in the nanomolar range (Kaff: ۰.۹ and ۰.۷ nM-۱, respectively), leading to marked inhibition of alpha-hemolysin-mediated lysis of rabbit RBCs (۷۳% and ۸۴% inhibition; respectively). Conclusion: SP۱۹۲ and SP۲۲۰ scFvs can potentially be used as alpha-hemolysin-neutralizing agents in conjunction with conventional antibiotics to combat S. aureus infections.
کلیدواژه ها:
Hemolysins ، Monoclonal antibody ، Single-chain variable - fragment ، Staphylococcal infections ، Staphylococcus aureus
نویسندگان
Somayeh Piri-Gavgani
Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
Mostafa Ghanei
Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
Abolfazl Fateh
Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
Seyed Davar Siadat
Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
Leila Nematollahi
Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
Fatemeh Rahimi-Jamnani
Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :